Stock 688139 QINGDAO HAIER BIOMEDICAL CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

News Qingdao Haier Biomedical Co.,Ltd

Equities

688139

CNE100003P25

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-23 pm EDT 		5-day change 1st Jan Change
34.7 CNY +3.77% Intraday chart for Qingdao Haier Biomedical Co.,Ltd +11.08% -14.36%
Apr. 02 Tranche Update on Qingdao Haier Biomedical Co.,Ltd's Equity Buyback Plan announced on February 9, 2024. CI
Feb. 26 Qingdao Haier Biomedical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Tranche Update on Qingdao Haier Biomedical Co.,Ltd's Equity Buyback Plan announced on February 9, 2024.
CI
Qingdao Haier Biomedical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Qingdao Haier Biomedical Co.,Ltd announces an Equity Buyback for CNY 50 million worth of its shares.
CI
Qingdao Haier Biomedical Co.,Ltd authorizes a Buyback Plan.
CI
CICC Elects Chairman, Vice Chairman
MT
Jefferies Adjusts Qingdao Haier Biomedical’s Price Target to 80 Yuan From 100 Yuan, Keeps at Buy
MT
Qingdao Haier Biomedical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Jefferies Adjusts Qingdao Haier Biomedical's Price Target to 100 Yuan From 120 Yuan, Keeps at Buy
MT
Qingdao Haier Biomedical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Shanghai Chaoli'an Technology Co., Ltd. announced that it expects to receive CNY 43 million in funding from Qingdao Haier Biomedical Co.,Ltd
CI
Qingdao Haier Biomedical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Jefferies Adjusts Qingdao Haier Biomedical’s Price Target to 120 Yuan From 126 Yuan, Keeps at Buy
MT
Qingdao Haier Biomedical Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Tranche Update on Qingdao Haier Biomedical Co., Ltd's Equity Buyback Plan announced on February 7, 2022.
CI
Qingdao Haier Biomedical Co., Ltd's Equity Buyback announced on February 7, 2022, has expired with 1,459,586 shares, representing 0.46% for CNY 99.69 million.
CI
Tranche Update on Qingdao Haier Biomedical Co., Ltd's Equity Buyback Plan announced on February 7, 2022.
CI
Beijing residents break free from COVID lockdown
RE
Qingdao Haier Biomedical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Qingdao Haier Biomedical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Basecare Medical and Haier Biomedical Join Forces to Build Cryopreservation Solutions
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 688139 Stock
  4. News Qingdao Haier Biomedical Co.,Ltd